DJIA 17,435.05 47.84 0.28%
NASDAQ 4,724.07 42.57 0.91%
S&P 500 2,041.06 11.51 0.57%
market minute promo

United Therapeutics Corp (NASDAQ: UTHR)



company name or ticker
Company Photos
(Click to zoom)

Weakness Seen in Alcobra (ADHD): Stock Falls 6.6% - Tale of the Tape

Arena Pharmaceuticals' APD811 Gets Orphan Drug Status - Analyst Blog

Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor - Analys

Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor - Analyst Blog

United Therapeutics Soars on Remodulin Patent Case Win - Analyst Blog

United Therapeutics Soars on Remodulin Patent Case Win - Analyst Blog

United Therapeutics (UTHR) Shares March Higher, Can It Continue? - Tale of the Tape

United Therapeutics (UTHR) Shares March Higher, Can It Continue? - Tale of the Tape

Stock To Watch: United Therapeutics (UTHR) In Perilous Reversal

Why United Therapeutics Corporation Stock Skyrocketed

United Therapeutics stock is among today's top gainers after it announces a favorable legal ruling regarding its best-selling drug, Remodulin.

Sector Update: Health Care

Sector Update: Health Care Stocks Ahead Just Before Bell; United Therapeutics Soars After Winning Fe

Sector Update: Health Care Stocks Ahead Just Before Bell; United Therapeutics Soars After Winning Fed Court Decision

Barbarian At The Gate: United Therapeutics (UTHR)

See More Articles...